Utilizing the pER8:GUS transgenic plant bioassay system to monitor estrogenic activity-guided fractionation, one new constituent, erycaffrain A, together with 11 known compounds were isolated from the ethanolic extract of Erythrina caffra. The structures of the isolated compounds were identified in combination with spectroscopic analyses. This is the first study reporting the estrogenic activity of E. caffra. The new compound exhibited as a SREM, but also showed both estrogenic and anti-estrogenic activities in the MCF-7 cancer cell model. Several known phytoestrogens in this plant also revealed possible new functions for E. caffra stem.
Erythrina caffra Thunb. (Leguminosae, coral tree) is found in South Africa's coastal sheltered forests and along wooded rivers. The leaves of E. caffra are known as a poison to cattle [1] . Many compounds have also been isolated from this plant, i.e. erythrina alkaloids, 3-indolyl propionate alkaloids [2] , isoflavonoids, flavonoids, and fatty alcohols. Erythrina alkaloids are known to be highly toxic [2] , but the traditional uses strongly suggest antibacterial, anti-inflammatory and analgesic effects [1] . Alkaloids were found in the stem bark [3] [4] , and flavonoids and isoflavonoids in the flowers [3, 5] . The stem bark of E. caffra has been used as an analgesic and anti-inflammatory [1], but the estrogenic activity of E. caffra has never been investigated.
To discovery new phyto-SERMs, natural product extracts have been screened using the transgenic plant assay system [6] [7] [8] [9] . The ethanolic extract of E. caffra exhibited potent estrogenic activity with a minimum active concentration (MAC) of 1.56 g/mL. In addition to its significant estrogenic activity, the extract exhibited potential anti-inflammatory activity. Therefore, it was selected for further phytochemical investigation directed by bioactivity-guided fractionation of its secondary metabolites for their estrogenic activity.
The fresh plant of E. caffra was separated into stem, stem bark, leaf and roots, and each was extracted with ethanol to yield four extracts. Among them, the extract of the stems exhibited the most potent estrogenic activity, and was selected for further chromatography. The ethanolic extract was partitioned between EtOAc and H 2 O to obtain the estrogen active EtOAc layer. This was subjected to partition between solvents of different polarities to obtain n-hexane, MeOH, n-BuOH, and water layers. Chromatographic fractionation of the MeOH layer (the most active) afforded 23 sub-fractions. By utilizing Sephadex LH-20, and normal and reverse column chromatography, one new isoflavone derivative, erycaffrain A (1), was obtained together with the known isoflavonoids, genistein (2) [10], 2'-hydroxygenistein (3) [11] , genistin (4) [12] , daidzein (5) [13] , 3'-hydroxydaidzein (6) [14] , daidzin (7) [13] , liquiritigenin (8) [15] , isoliquiritigenin (9) [16] , and three steroids (1012) [17] (Figure 1 ). The structures of the isolated compounds were elucidated by spectroscopic methods. The spectral data of the known compounds were compared with those reported in the literature to identify the structures.
Compound 1 was obtained as a brown amorphous solid. The HRESIMS of 1 showed a molecular ion at m/z 393.0948 [M + Na] + , (Table 1) . Importantly, these data were similar to those reported for the known compound, erysenegalensein D [18] .
The HMBC spectrum showed correlations between H-4 (δ H 4.74 and 4.90) and C-2 (δ C 77.1) / C-5 (δ C 18.9), as well as between H-5 (δ H 1.83) and C-2 (δ C 77.1) / C-4 (δ C 111.1) indicating the presence of a 2-methylpent-1-en-3-ol moiety ( Figure 2 ). Moreover, the HMBC correlations between methylene protons (H-1, δ H 3.00 and 3.10) and carbon signals of ring A (δ C 106.1, 157.4, and 167.0) indicated that the unusual 2-methylpent-1-en-3-ol moiety was attached to C-8, as in erysenegalensein D ( Figure 2 ) [18] .
The HMBC correlations between one aromatic proton (H-6, δ H 6.31) and C-5 (δ C 162.4) / C-10 (δ C 105.8), together with the above data suggested that C-5 and C-7 were substituted by hydroxy functionalities. Thus, the structure of 1 was elucidated as 3-(2,4dihydroxyphenyl)-5,7-dihydroxy-8-(2-hydroxy-3-methylbut-3enyl)-4H-chromen-4-one, and was given the trivial name erycaffrain A.
The isolated compounds were determined for their estrogenic activity in the pER8:GUS transgenic plant assay system [6] . The new compound, erycaffrain A (1), exhibited moderate estrogenic activity with a MAC of 1.25 g/mL in the pER8:GUS plant assay system. The known compounds 2, 3, and 4 exhibited significant estrogenic activity with MAC ≦ 0.05 M ( Table 2 ). The isolated isoflavonoids, genistein (2), 2'-hydroxygenistein (3), genistin (4), daidzein (5), 3'-hydroxydaidzein (6) , and daidzin (7) have been reported for their estrogenic and anti-estrogenic activities [19] [20] [21] . Among them, genistein (2), 2'-hydroxygenistein (3), and daidzein (4), which have been proposed as phyto-SERMs [9, [19] [20] , are the major components of E. caffra stem. The estrogenic and antiestrogenic activities of 1 were also determined by the in vitro MCF-7 reporter assay. The results showed that 1 did not induce SEAP activity in the MCF-7 cell line, which means that it is not estrogen active at 10 and 20 g/mL. However, 1 exhibited anti-estrogenic activity against E2-induced SEAP activity in a dose-dependent manner (Figure 3 ). Estrogenic constituents from Erythrina caffra Natural Product Communications Vol. 11 (8) 
Using the estrogenic activity-guided isolation, the estrogenic components of E. caffra were distinguished from other type compounds, such as erythrina alkaloids and 3-indolyl propionate alkaloid [2] . In summary, the results provide evidence for new biofunctions of E. caffra stem. Different parts of E. caffra, with different chemical compositions, may be used for different purposes. 
Extraction and isolation:
Fresh plants of E. caffra (10.0 kg) were separated into stem, stem bark, leaf, and roots. Each was extracted 3 times with EtOH at room temperature. The EtOH extract of the stems, which exhibited the most potent estrogenic activity, was subjected to further bioactivity-guided fractionation.
The EtOH extract was concentrated on a rotary evaporator, and the dried extract (81.6 g) was partitioned between EtOAc:MeOH:water (9:1:10) to yield 2 layers, EA layer (38.6 g) and water layer (42.8 g). The EA layer, after concentration to dryness, was partitioned between n-hexane:MeOH (1:1) to yield a MeOH layer (20.1 g) and a hexane layer (18.1 g). The MeOH layer was chromatographed on silica gel using mixtures of n-hexane-EtOAc of increasing polarity (10:1→0:1), yielding 23 fractions. Fraction (Fr.) 4 (114.5 mg) was recrystallized in CH 2 Cl 2 -MeOH (20:1) and a mixture of 10 and 11 was obtained (32.5 mg).
Fr. 15 (1.71 g) was fractionated on silica gel using mixtures of CH 2 Cl 2 -MeOH of increasing polarity (20:1→0:1), yielding sixteen sub-fractions. Sub-fraction 15-4 (6.36 mg) was chromatographed on C 18 
Transgenic plant material and estrogen-like reporter assay:
The arabidopsis pER8:GUS line, with an estrogen receptor-based transactivator XVE (pER8) system, was originally developed by Brand et al. [22] . The pER8:GUS seeds were grown in the dark for 36 h at 4C on medium (1/2MS, 1% sucrose, 0.8% phytoagar) for vernalization, and then germinated under white light for 72 h at 24C. The plants were transferred to a 24-well microtiter plate in either the presence or absence of test samples and incubated at 24C for 48 h. Plants cultured with 0.31-10 nM 17 ・-estradiol were taken as a positive control [6] .
Histochemical assay: After incubation in either the presence or absence of test samples, transgenic plants were soaked in 0.2 mL per well of the GUS assay solution [50 mM Na 3 PO 4 buffer (pH 7.0), 10 mM EDTA (pH 8.0), 2 mM X-Gluc, 0.5 mM K 3 Fe(CN) 6 , 0.5 mM K 4 Fe(CN) 6 , and 0.1% Triton X-100] in a 24-well plate and incubated for either 3 h or overnight at 37C. The sections were rinsed with 70% aqueous EtOH for 1 h to remove the chlorophyll [23] . Using a ZEISS Axiovert 200 inverse microscope, samples were examined for GUS staining and photographed with a digital camera [9] .
Reporter gene assay:
Human breast adenocarcinoma cells MCF-7 obtained from Bioresource Collection and Research Center (BCRC) were cultured in phenol-red free minimum essential medium (MEM) supplemented with dextran-charcoal treated serum, 2 M
